Insightra Medical Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Insightra Medical Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011110
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Insightra Medical Inc (Insightra Medical), a subsidiary of GPB Life Science Holdings LLC is a medical device company that develops disposable devices. The company offers cardiovascular and surgical solutions. Its cardiovascular solutions include Ultra 7FR IAB and modulare. The Modulare Catheter Stabilization Device is used for patients who require access catheters. The company’s surgical solutions include octomesh, proflor and TIGR matrix. The octomesh is designed for ventral hernia repair and proflor is designed for inguinal hernia repair. It products are used in the therapeutic areas of cardiology, surgery, endoscopy, and urology. Insightra Medical is headquartered in Clarksville, Tennessee, the US.

Insightra Medical Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Insightra Medical Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Insightra Medical Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Insightra Medical Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Insightra Medical Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Insightra Medical Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Insightra Medical Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Insightra Medical Raises USD5 Million in Financing Round 10
Insightra Medical Raises USD2.8 Million in Venture Financing 11
Insightra Medical Raises US$6 Milliion In Venture Financing 12
Insightra Medical Raises Funds Through Series C Financing 13
Insightra Medical Raises US$7.7 Million Through Venture Financing 14
Partnerships 15
Medline Industries Enters Into Distribution Agreement With Insightra Medical 15
Asset Transactions 16
Symmetry Surgical Acquires Low Profile Retractor Product from Insightra Medical for USD0.4 Million 16
Insightra Medical Inc – Key Competitors 17
Insightra Medical Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Insightra Medical Inc, Medical Equipment, Key Facts 2
Insightra Medical Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Insightra Medical Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Insightra Medical Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Insightra Medical Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Insightra Medical Inc, Deals By Market, 2011 to YTD 2017 8
Insightra Medical Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Insightra Medical Raises USD5 Million in Financing Round 10
Insightra Medical Raises USD2.8 Million in Venture Financing 11
Insightra Medical Raises US$6 Milliion In Venture Financing 12
Insightra Medical Raises Funds Through Series C Financing 13
Insightra Medical Raises US$7.7 Million Through Venture Financing 14
Medline Industries Enters Into Distribution Agreement With Insightra Medical 15
Symmetry Surgical Acquires Low Profile Retractor Product from Insightra Medical for USD0.4 Million 16
Insightra Medical Inc, Key Competitors 17
Insightra Medical Inc, Subsidiaries 18

★海外企業調査レポート[Insightra Medical Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Alliance MMA, Inc. (AMMA):企業の財務・戦略的SWOT分析
    Alliance MMA, Inc. (AMMA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Telkom SA SOC Limited:企業の戦略・SWOT・財務情報
    Telkom SA SOC Limited - Strategy, SWOT and Corporate Finance Report Summary Telkom SA SOC Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • China Railway Construction Corporation Ltd:戦略・SWOT・企業財務分析
    China Railway Construction Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary China Railway Construction Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Valaris Plc (VAL):企業の財務・戦略的SWOT分析
    Valaris Plc (VAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Biogen Inc (BIIB):企業の財務・戦略的SWOT分析
    Biogen Inc (BIIB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Champions Oncology Inc (CSBR):企業の財務・戦略的SWOT分析
    Summary Champions Oncology Inc (Champions), formerly Champions Biotechnology Inc, is a developer of advanced technology solutions and services to personalize the development and use of oncology drugs. The company’s technology platform is an approach based upon the implantation of primary human tumor …
  • Vivendi S.A.:戦略・SWOT・企業財務分析
    Vivendi S.A. - Strategy, SWOT and Corporate Finance Report Summary Vivendi S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Vivakor Inc (VIVK):企業の財務・戦略的SWOT分析
    Summary Vivakor Inc (Vivakor) is a technology and asset acquisition company that creates, acquires and accumulates distinct assets, intellectual properties, and various technologies. The company concentrates on precious metals extraction in the US. It also concentrates on oil extraction from shallow …
  • Enthera Srl:製薬・医療:M&Aディール及び事業提携情報
    Summary Enthera Srl (Enthera), a subsidiary of BiovelocITA Srl, is a biotechnology company, which strives to discover novel medicines for the treatment of diabetes and related gastrointestinal disorders. Gastrointestinal symptoms such as diarrhea and abdominal pain among diabetics are referred to as …
  • UniQure NV (QURE):製薬・医療:M&Aディール及び事業提携情報
    Summary UniQure NV (UniQure) develops and markets gene therapy products. The company develops adeno-associated virus based gene therapies using its gene technology platform. UniQure offers clinical and preclinical programs for lipoprotein lipase deficiency, hemophilia A and B, Huntington’s disease, …
  • HESTA Super Fund:企業の戦略的SWOT分析
    HESTA Super Fund - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Solocal Group (LOCAL):企業の財務・戦略的SWOT分析
    Solocal Group (LOCAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • James Cropper PLC (CRPR):企業の財務・戦略的SWOT分析
    James Cropper PLC (CRPR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • PDS Biotechnology Corp-製薬・医療分野:企業M&A・提携分析
    Summary PDS Biotechnology Corp (PDS Biotechnology) is a biopharmaceutical company that develops immunotherapies and vaccines for cancer and infectious disease. The company uses versamune technology, which is immunostimulatory nanoparticle vaccine platform used for the development of cancer immunothe …
  • Tryton Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Tryton Medical Inc (Tryton Medical) is a medical device company that develops novel stent systems for the treatment of bifurcation lesions. The company offers tryton side branch coronary artery stent which is designed to treat, protect and secure coronary bifurcations. Its tryton side branch …
  • Akari Therapeutics Plc (AKTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Akari Therapeutics Plc (Akari), formerly Celsus Therapeutics Plc is a biopharmaceutical company that develops treatments for rare and orphan autoimmune and inflammatory diseases. The company offers coversin drugs that act on complement component-C5 that helps in preventing the release of C5a …
  • Wellcome Trust Sanger Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary Wellcome Trust Sanger Institute (Sanger Institute) a subsidiary of Genome Research Ltd is a genomic discovery and research centre that carries out research and development in the areas of cellular and human genetics and infection genomics. It also provides postgraduate training on research a …
  • Cadence Bancorporation (CADE):企業の財務・戦略的SWOT分析
    Cadence Bancorporation (CADE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Kalgene Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Kalgene Pharmaceuticals Inc (Kalgene Pharmaceuticals) is a pre-clinical stage biotechnology company focused on the development of novel fusion protein therapeutic's for the treatment of neurodegenerative diseases. Its lead product candidate KAL-ABP, targets toxic amyloid beta oligomers that …
  • Ontario Teachers’ Pension Plan:企業のM&A・事業提携・投資動向
    Ontario Teachers' Pension Plan - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ontario Teachers' Pension Plan Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆